| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |